Your browser doesn't support javascript.
loading
Real-world data to build explainable trustworthy artificial intelligence models for prediction of immunotherapy efficacy in NSCLC patients.
Prelaj, Arsela; Galli, Edoardo Gregorio; Miskovic, Vanja; Pesenti, Mattia; Viscardi, Giuseppe; Pedica, Benedetta; Mazzeo, Laura; Bottiglieri, Achille; Provenzano, Leonardo; Spagnoletti, Andrea; Marinacci, Roberto; De Toma, Alessandro; Proto, Claudia; Ferrara, Roberto; Brambilla, Marta; Occhipinti, Mario; Manglaviti, Sara; Galli, Giulia; Signorelli, Diego; Giani, Claudia; Beninato, Teresa; Pircher, Chiara Carlotta; Rametta, Alessandro; Kosta, Sokol; Zanitti, Michele; Di Mauro, Maria Rosa; Rinaldi, Arturo; Di Gregorio, Settimio; Antonia, Martinetti; Garassino, Marina Chiara; de Braud, Filippo G M; Restelli, Marcello; Lo Russo, Giuseppe; Ganzinelli, Monica; Trovò, Francesco; Pedrocchi, Alessandra Laura Giulia.
Afiliación
  • Prelaj A; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy.
  • Galli EG; Department of Electronics, Information and Bioengineering, Politecnico di Milano, Milan, Italy.
  • Miskovic V; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy.
  • Pesenti M; Niguarda Cancer Center, Grande Ospedale Metropolitano Niguarda, Milan, Italy.
  • Viscardi G; Oncology Department, University of Milan, Milan, Italy.
  • Pedica B; Department of Electronics, Information and Bioengineering, Politecnico di Milano, Milan, Italy.
  • Mazzeo L; Department of Electronics, Information and Bioengineering, Politecnico di Milano, Milan, Italy.
  • Bottiglieri A; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy.
  • Provenzano L; Medical Oncology Unit, Department of Precision Medicine, University of Campania "Luigi Vanvitelli", Naples, Italy.
  • Spagnoletti A; Department of Electronics, Information and Bioengineering, Politecnico di Milano, Milan, Italy.
  • Marinacci R; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy.
  • De Toma A; Department of Electronics, Information and Bioengineering, Politecnico di Milano, Milan, Italy.
  • Proto C; Oncology Department, University of Milan, Milan, Italy.
  • Ferrara R; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy.
  • Brambilla M; Oncology Department, University of Milan, Milan, Italy.
  • Occhipinti M; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy.
  • Manglaviti S; Oncology Department, University of Milan, Milan, Italy.
  • Galli G; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy.
  • Signorelli D; Oncology Department, University of Milan, Milan, Italy.
  • Giani C; Department of Electronics, Information and Bioengineering, Politecnico di Milano, Milan, Italy.
  • Beninato T; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy.
  • Pircher CC; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy.
  • Rametta A; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy.
  • Kosta S; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy.
  • Zanitti M; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy.
  • Di Mauro MR; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy.
  • Rinaldi A; Medical Oncology Unit, Policlinico San Matteo Fondazione IRCCS, Pavia, Italy.
  • Di Gregorio S; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy.
  • Antonia M; Niguarda Cancer Center, Grande Ospedale Metropolitano Niguarda, Milan, Italy.
  • Garassino MC; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy.
  • de Braud FGM; Oncology Department, University of Milan, Milan, Italy.
  • Restelli M; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy.
  • Lo Russo G; Oncology Department, University of Milan, Milan, Italy.
  • Ganzinelli M; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy.
  • Trovò F; Oncology Department, University of Milan, Milan, Italy.
  • Pedrocchi ALG; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy.
Front Oncol ; 12: 1078822, 2022.
Article en En | MEDLINE | ID: mdl-36755856
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Front Oncol Año: 2022 Tipo del documento: Article País de afiliación: Italia Pais de publicación: Suiza
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Front Oncol Año: 2022 Tipo del documento: Article País de afiliación: Italia Pais de publicación: Suiza